Clinical Trial Update: Comparison Of 4 CP-690,550 Doses Vs. Placebo, Each Combined With Methotrexate, For The Treatment Of Rheumatoid Arthritis in Japan [Phase 2]

View source ↗

Summary

Phase 2 study in Japan evaluating four doses of tofacitinib (CP-690,550) versus placebo, each with methotrexate, for rheumatoid arthritis; results were posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Tofacitinib (tofacitinib)

Snippet

Sponsor: Pfizer | Conditions: Arthritis, Rheumatoid | Phase 2 | Status: COMPLETED | Results posted: 2013-01-25